|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 498/10 | (2006.01) |
| A61K 31/438 | (2006.01) | ||
| A61P 31/06 | (2006.01) |
| (11) | Number of the document | 3668879 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18752171.1 |
| Date of filing the European patent application | 2018-08-15 | |
| (97) | Date of publication of the European application | 2020-06-24 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-29 |
| (46) | Date of publication of the claims translation | 2022-03-25 |
| (86) | Number | PCT/EP2018/072143 |
| Date | 2018-08-15 |
| (87) | Number | WO 2019/034700 |
| Date | 2019-02-21 |
| (30) | Number | Date | Country code |
| 17382569 | 2017-08-16 | EP |
| (72) |
PORRAS DE FRANCISCO, Esther , ES
REMUIÑAN-BLANCO, Modesto Jesús , ES
BOUROTTE, Marilyne , FR
DEPREZ, Benoit , FR
WILLAND, Nicolas , FR
|
| (73) |
GlaxoSmithKline Intellectual Property Development Limited,
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY,
GB
Bioversys AG , Hochbergerstrasse 60c, 4057 Basel, CH |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauji junginiai |
| NOVEL COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 8 | 185.00 EUR |
| 2026-08-15 |